Yuhao Wang

Yuhao Wang

Auto-generated profile, based on publicly available information

Yuhao Wang

Zhejiang Provincial Key Laboratory of Pancreatic Disease of the First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Science
Verified
Journal Article
Closed access
PDF file
YWYuhao Wang
Yuhao Wang
ZKZheng Kuang
Zheng Kuang
XYXiaofei Yu
Xiaofei Yu
KRKelly A. Ruhn
Kelly A. Ruhn
MKMasato Kubo
Masato Kubo
LHLora V. Hooper
Lora V. Hooper
Light, fat, and commensals: The gut microbiota facilitates energy harvest from food and transfers it into fat storage. Working in mice, Wang et al. found that an epithelial cell circadian transcription factor, NFIL3, is involved in regulating body composition through lipid uptake. Flagellin and lipopolysaccharide produced by certain microbes tuned the amplitude of oscillation of NFIL3 through innate lymphoid cell (ILC3) signaling, STAT3, and the epithelial cell clock. Such interactions may help to explain why circadian clock disruptions in humans, arising from shift work or international travel, frequently track with metabolic diseases, including obesity, diabetes, and cardiovascular disease. Science , this issue p. 912

8 September 2017 in Science
Verified
Journal Article
Closed access
PDF file
SBShai Bel
Shai Bel
MPMihir Pendse
Mihir Pendse
YWYuhao Wang
Yuhao Wang
YLYun Li
Yun Li
KRKelly A. Ruhn
Kelly A. Ruhn
LHLora V. Hooper
Lora V. Hooper
Foiling bad bugs' sneaky tricks: Intestinal pathogens can invade host cells and disrupt critical cellular functions, including secretion. Secretion is necessary for the delivery of antimicrobial proteins that kill pathogenic bacteria. Bel et al. show that when intestinal epithelial cells sense an invading bacterial pathogen, they “reroute” the antimicrobial protein lysozyme through an alternative autophagy-based secretion pathway (see the Perspective by Kaser and Blumberg). This ensures lysozyme delivery to the gut lumen, which protects against further bacterial invasion. Secretory autophagy was triggered by endoplasmic reticulum stress and required signals from type 3 innate lymphoid cells. Thus, the innate immune response to gut pathogens co-opts autophagy in intestinal immune defense. Science , this issue p. 1047 ; see also p. 976

27 September 2019 in Science
Verified
Journal Article
Closed access
PDF file
ZKZheng Kuang
Zheng Kuang
YWYuhao Wang
Yuhao Wang
YLYun Li
Yun Li
YYYe Ye
Ye Ye
KRKelly A. Ruhn
Kelly A. Ruhn
LHLora V. Hooper
Lora V. Hooper
Microbial entrainment of metabolism: The metabolism of mammals is synchronized to daily cycles relating to sleep and mealtimes. It is not surprising that the gut microbiota, which aids in digestion, should also display daily cycling. Kuang et al. found that the gut microbiota can mediate daily cycles epigenetically (see the Perspective by Bishehsari and Keshavarzian). The microbiota induces rhythmic expression of histone deacetylase 3 (HDAC3) in epithelial cells of the small intestine, but not those of the colon. HDAC3 expression drives oscillations in intestinal metabolic gene expression, especially for nutrient transport and lipid metabolism. HDAC3 also directly activates estrogen-related receptor α, which promotes lipid absorption. Consequently, mice that lack a gut microbiota lack daily regulation of their metabolism and become obese on high-fat chow. Disruption of HDAC3 cycling could be an explanation for human obesity associated with antibiotic damage to the microbiota and with sleep disruption caused by jet lag and nighttime working. Science , this issue p. 1428 ; see also p. 1379

25 August 2023 in Science
Verified
Journal Article
Closed access
YWYuhao Wang
Yuhao Wang
MWMeng Wang
Meng Wang
JCJiaxin Chen
Jiaxin Chen
YLYun Li
Yun Li
ZKZheng Kuang
Zheng Kuang
LHLora V. Hooper
Lora V. Hooper
The intestinal microbiota regulates mammalian lipid absorption, metabolism, and storage. We report that the microbiota reprograms intestinal lipid metabolism in mice by repressing the expression of long noncoding RNA (lncRNA) Snhg9 (small nucleolar RNA host gene 9) in small intestinal epithelial cells. Snhg9 suppressed the activity of peroxisome proliferator–activated receptor γ (PPARγ)—a central regulator of lipid metabolism—by dissociating the PPARγ inhibitor sirtuin 1 from cell cycle and apoptosis protein 2 (CCAR2). Forced expression of Snhg9 in the intestinal epithelium of conventional mice impaired lipid absorption, reduced body fat, and protected against diet-induced obesity. The microbiota repressed Snhg9 expression through an immune relay encompassing myeloid cells and group 3 innate lymphoid cells. Our findings thus identify an unanticipated role for a lncRNA in microbial control of host metabolism.

5 November 2021 in Science
Verified
Journal Article
Closed access
ZHZehan Hu
Zehan Hu
CZChenlu Zhang
Chenlu Zhang
LSLuis Sifuentes-Dominguez
Luis Sifuentes-Dominguez
CZChristina M. Zarek
Christina M. Zarek
DPDaniel C. Propheter
Daniel C. Propheter
LHLora V. Hooper
Lora V. Hooper
AMPlifying type 2 immunity: Antimicrobial proteins (AMPs) are a frontline defense against pathogenic microorganisms at mucosal surfaces. These cationic molecules inactivate their targets primarily by disrupting cell walls and membranes. Hu et al . found that small proline-rich protein 2A (SPRR2A) is a bactericidal protein produced in the gut that targets Gram-positive bacteria and is phylogenetically distinct from all other known AMPs (see the Perspective by Harris and Wickramasinghe). SPRR2A production is selectively enhanced by type 2 cytokines such as interleukin-4 and -13 that are elicited by helminth infection. Mice lacking SPRR2A are unable to prevent intestinal bacteria from invading the intestinal barrier after helminths damage the intestinal epithelium. SPRR2A is thus a critical component of type 2 immunity that protects against the bacterial invasion and dissemination that follow helminth infection. —STS

21 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YMYanfei Ma
Yanfei Ma
YZYifan Zhong
Yifan Zhong
WTWenjie Tang
Wenjie Tang
TVTeresa G. Valencak
Teresa G. Valencak
JLJingliang Liu
Jingliang Liu
Haifeng WangHaifeng Wang
Haifeng Wang
Metabolic syndrome (MetS) is a difficult-to-manage disease that poses a significant risk to human health. Here, we show that the supplementation of Lactobacillus reuteri ZJ617 ameliorates symptoms of MetS in mice induced by the high-fat diet. L. reuteri ZJ617 modulates host metabolism by interacting with the microbiome, resulting in the production of spermidine synthesized by the microbiota. L. reuteri ZJ617 serves as a source of substrates for the microbiota to synthesize spermidine, hence preventing the decline of bacteria responsible for spermidine production. Spermidine treatment mimics the metabolic effects of L. reuteri ZJ617, whereas pharmacological inhibition of spermidine biosynthesis in mice abolishes these benefits. Our findings reveal the mechanism by which L. reuteri ZJ617 alleviates MetS symptoms and provide support for its potential use as a probiotic for promoting metabolic health.